{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:36Z","timestamp":1790645076124,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017016","name":"Geriatric Research Education and Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["UFI 11\/32"],"award-info":[{"award-number":["UFI 11\/32"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neuropharm.2015.09.003","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T21:23:03Z","timestamp":1441747383000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine"],"prefix":"10.1016","volume":"101","author":[{"given":"Patricia","family":"Szot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Miguelez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Vidaurrazaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Ugedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Sikkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray A.","family":"Raskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.09.003_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-2012-112003","article-title":"Apathy and depression in mild Alzheimer's disease: a cross-sectional study using diagnostic criteria","volume":"31","author":"Benoit","year":"2012","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/JGP.0b013e318190b8d8","article-title":"Patterns of mild cognitive impairment after treatment of depression in the elderly","volume":"17","author":"Bhalla","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.32.2.164","article-title":"Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia","volume":"32","author":"Bondareff","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer's pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","article-title":"The pathological process underlying Alzheimer's disease in individuals under thirty","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/WCO.0b013e32835a3432","article-title":"Where, when, and in what form does sporadic Alzheimer's disease begin?","volume":"25","author":"Braak","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer's disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neurobiolaging.2012.02.031","article-title":"Age-related appearance of dendritic inclusions in catecholaminergic brainstem neurons","volume":"34","author":"Braak","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.euroneuro.2014.02.007","article-title":"Altered neuronal activity and differential sensitivity to acute antidepressants of locus coeruleus and dorsal raphe nucleus in Wistar Kyoto rats: a comparative study with Srague Dawley and Wistar rats","volume":"24","author":"Bruzos-Cidon","year":"2014","journal-title":"Eur. Neuropsychoparmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib10","series-title":"The Neurobiological Basis of Suicide","article-title":"Chapter 3: noradrenergic dysfunction in depressed and suicide","author":"Chandley","year":"2012"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer's type and in Parkinson's disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00427352","article-title":"Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness","volume":"64","author":"Coppen","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of parkinsonism: chronic treatment with L-DOPA","volume":"280","author":"Cotzias","year":"1969","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)29424-6","article-title":"Use of dopamine-\u03b2-hydroxylase deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs","volume":"298","author":"Cryan","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib16","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1073\/pnas.0401080101","article-title":"Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors","volume":"101","author":"Cryan","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(02)00011-3","article-title":"Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness","volume":"74","author":"Ehnvall","year":"2003","journal-title":"J.\u00a0Affect Dis."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nbd.2011.01.024","article-title":"Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkisnon's disease","volume":"42","author":"Francardo","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1176\/appi.ajp.2014.13060821","article-title":"Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study","volume":"171","author":"Geda","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.euroneuro.2006.07.004","article-title":"Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function","volume":"17","author":"Gobbi","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-3223(00)00936-7","article-title":"Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity","volume":"49","author":"Grant","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib23","first-page":"943","article-title":"Behavioral depression following clonidine withdrawal: a new animal model of long-lasting depression?","volume":"22","author":"Hoffman","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130050569","article-title":"A\u00a0partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in frontal cortex: a microdialysis study in\u00a0vivo","volume":"136","author":"Hughes","year":"1998","journal-title":"Pscyhopharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/PL00004942","article-title":"Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in\u00a0vivo microdialysis study in anesthetized rats","volume":"355","author":"Kask","year":"1997","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0006-3223(99)00164-X","article-title":"Corticotropin-releasing factor, norepinephrine, and stress","volume":"46","author":"Koob","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(97)01276-4","article-title":"Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?","volume":"337","author":"Lahmame","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jagp.2013.02.004","article-title":"Cortical changes associated with depression and antidepressants use in Alzheimer's and Lewy body dementia: an MRI surface-based morphometric study","volume":"22","author":"Lebedev","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.biopsych.2011.12.024","article-title":"Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions","volume":"71","author":"Lee","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S1041610206003607","article-title":"Persistent mild cognitive impairment in geriatric depression","volume":"19","author":"Lee","year":"2007","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0893-133X(99)00100-1","article-title":"Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test","volume":"22","author":"Lopez-Rubalcava","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0306-4522(86)90155-7","article-title":"Efferent projections of nucleus locus coeruleus: topographic organization of cells of origin demonstrated by three-dimensional reconstruction","volume":"18","author":"Loughlin","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0306-4522(86)90156-9","article-title":"Efferent projections of nucleus locus coeruleus noradrenaline neurons: morphologic subpopulations have different efferent targets","volume":"18","author":"Loughlin","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer's disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3940(86)90336-8","article-title":"Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged","volume":"64","author":"Marcyniuk","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainres.2010.12.015","article-title":"Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease","volume":"1373","author":"McMillan","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S146114571000043X","article-title":"Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease","volume":"14","author":"Miguelez","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib38","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer's type: a prospective cohort study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioral despair\u201d in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib40","first-page":"287","article-title":"Altered activity of the locus coeruleus in an animal model of depression","volume":"1","author":"Simson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0028-3908(89)90147-0","article-title":"Blockade of alpha 2-adrenergic receptors, but not blockade of gamma-aminobutyric acid, serotonin, or opiate receptors, augments responsiveness of locus coeruleus neurons to excitatory stimulation","volume":"28","author":"Simson","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0028-3908(86)90232-7","article-title":"Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus","volume":"25","author":"Simson","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S003329170004962X","article-title":"3-Methoxy-4-hydroxyphenylglycol in depression","volume":"3","author":"Shaw","year":"1973","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2014.08.014","article-title":"The storm before the quiet: neuronal hyperactivity and A\u03b2 in the presymptomatic stages of Alzheimer's disease","volume":"36","author":"Stargardt","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainresrev.2011.02.002","article-title":"The role of the central noradrenergic system in behavioral inhibition","volume":"67","author":"Stone","year":"2011","journal-title":"Brain Res. Rev."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.09.003_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1167.2012.03476.x","article-title":"Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system","volume":"53","author":"Szot","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00184","article-title":"Sequential loss of LC noradrenergic and dopaminergic neurons results in a correlation of dopaminergic neuronal number to striatal dopamine concentration","volume":"3","author":"Szot","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2012.04.046","article-title":"Lesioning noradrenergic neurons of the locus coeruleus in C57Bl\/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling","volume":"216","author":"Szot","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib49","doi-asserted-by":"crossref","first-page":"10985","DOI":"10.1523\/JNEUROSCI.19-24-10985.1999","article-title":"Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli","volume":"19","author":"Szot","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","article-title":"Compensatory changes in the noradrenergic nervous system in the locus coeruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies","volume":"26","author":"Szot","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib51","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1046\/j.1471-4159.1998.70062468.x","article-title":"Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine b-hydroxylase","volume":"70","author":"Thomas","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jad.2007.06.010","article-title":"Association of a dopamine beta-hydroxylase gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction","volume":"106","author":"Togsverd","year":"2008","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0022-510X(81)90031-9","article-title":"Cell loss in the locus coeruleus in senile dementia of the Alzheimer's type","volume":"49","author":"Tomlinson","year":"1981","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1017\/S1461145712000971","article-title":"Role of GIRK channels on the noradrenergic transmission in\u00a0vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice","volume":"16","author":"Torrecilla","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-130596","article-title":"Behavioral syndromes in mild cognitive impairment and Alzheimer's disease","volume":"38","author":"Van der Mussele","year":"2014","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JGP.0b013e31823e2cc7","article-title":"Neural correlates associated with cognitive decline in late-life depression","volume":"20","author":"Wang","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.09.003_bib57","first-page":"191","article-title":"Depression in an animal model: focus on the locus ceruleus","volume":"123","author":"Weiss","year":"1986","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib58","first-page":"240","article-title":"Neurochemical and electrophysiological events underlying stress-induced depression in an animal model","volume":"245","author":"Weiss","year":"1988","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib59","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1017\/S1461145708009474","article-title":"Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons","volume":"12","author":"West","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.97.1.325","article-title":"Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone","volume":"97","author":"Wong","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.003_bib62","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1176\/appi.ajp.160.5.857","article-title":"A\u00a0collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease","volume":"160","author":"Zubenko","year":"2003","journal-title":"Am. J. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:57:56Z","timestamp":1762214276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815300964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":62,"alternative-id":["S0028390815300964"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}